A left ventricular lead implantation at the latest site based on four-dimensional computed tomography: a case report

Akinori Matsumoto1, Ryo Ogawa2, Masafumi Maeda2

  • 1Department of Cardiovascular Internal Medicine, Akashi Medical Center, 743-33 Yagi, Ohkubo-cho, Akashi, Hyogo, Japan.

Insights

Four-dimensional computed tomography (4DCT) identified the optimal left ventricular (LV) lead placement site for cardiac resynchronization therapy (CRT) in a heart failure patient, improving outcomes when traditional methods failed.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Cardiac resynchronization therapy (CRT) is a treatment for severe heart failure (HF) but is ineffective in about 30% of patients.
  • Four-dimensional computed tomography (4DCT) has shown utility in pre-operative planning for transcatheter aortic valve interventions.
  • 4DCT allows detailed evaluation of myocardial displacement throughout the cardiac cycle.

Purpose of the Study:

  • To investigate the potential of 4DCT in identifying optimal left ventricular (LV) lead implantation sites for CRT.
  • To evaluate the efficacy of 4DCT-guided LV lead placement in a patient with heart failure and a narrow QRS complex.

Main Methods:

  • A patient with severe LV dysfunction and HF requiring CRT was assessed.
  • Despite a narrow QRS and lack of echocardiographic dyssynchrony, LV lead implantation was guided by 4DCT to the most delayed myocardial region.
  • Patient outcomes were monitored three months post-implantation.

Main Results:

  • The 4DCT identified a suitable LV lead implantation site not detected by echocardiography.
  • Following implantation at the 4DCT-identified site, the patient showed improved ejection fraction and reduced cardiothoracic ratio.
  • The CRT was effective in this patient, suggesting successful lead placement.

Conclusions:

  • 4DCT can be a valuable tool for identifying effective LV lead implantation sites for CRT, particularly when traditional methods are inconclusive.
  • This case demonstrates the potential of 4DCT to improve CRT outcomes in selected heart failure patients.
Abstract